Subscribe To
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at […] The post Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference appeared first...
Read More
Posted: Feb 10 2023, 22:00
Author Name: forextv
Views: 082353